Evidence map›Paper›PMID 40844704›Full record

ReviewArchives of microbiology2025

The interactions of natural compounds with Escherichia coli motility, attachment, communication systems, and mature biofilm.

Milad Kashi, Mahdieh Varseh, Marzieh Askarinia, Reza Ghasemikhah, Zahra Chegini, Aref Shariati

Abstract readReview
PubMed Publisher
In one paragraph

Review in Archives of microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Deep Eutectic Solvent-Based Emulsion ContainingAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Milad KashiStudent research committee, Arak University of Medical Sciences, Arak, Iran.
Mahdieh VarsehStudent Research Committee, Khomein University of Medical Sciences, Khomein, Iran.
Marzieh AskariniaDepartment of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Reza GhasemikhahInfectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran.
Zahra CheginiDepartment of Microbiology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.
Aref ShariatiInfectious Diseases Research Center (IDRC), Arak University of Medical Sciences, Arak, Iran. arefshariati0111@gmail.com.

Funding

Arak University of Medical Sciences 4745
6 · The paper itself

Abstract

Bacterial biofilms play a significant role in increasing antibiotic resistance and the pathogenesis of Escherichia coli; their control is a major challenge in treating bacterial infections. In recent years, natural compounds have emerged as effective alternatives for inhibiting the formation and destruction of bacterial biofilms. Natural compounds such as curcumin, cinnamaldehyde, eugenol, carvacrol, quercetin, resveratrol, thymol, citral, and catechin are noteworthy in hindering and destroying E. coli biofilms. They inhibit bacterial motility (swarming and swimming), reducing attachment to surfaces, and downregulate genes related to attachment and motility (fimH, csgABC, sfaAS, papG, fliAC, flhCD, and motAB). Natural compounds can also disrupt the bacterial communication system and cause changes in the expression of luxS, sdiA, tnaA, qseBC, bssS, and lsrR genes. Studies have also shown that natural compounds can destroy mature biofilms' structure and decrease biofilm exopolysaccharides' production. This impact makes the bacteria more sensitive to the antimicrobial agents. However, one of the biggest challenges in using natural compounds is their low stability and restricted bioavailability in biological environments. For this reason, utilizing nanoparticles and novel drug delivery systems can improve these compounds' stability, penetrability, and efficacy. This article reviews the antibiofilm potential of natural compounds, their mechanisms of activity in hindering and destroying E. coli biofilms, and the role of nanotechnology in improving the performance of these compounds.

Indexed as

Anti-Bacterial AgentsBacterial AdhesionBiofilmsBiological ProductsEscherichia coliGene Expression Regulation, BacterialQuorum SensingAnti-Bacterial AgentsBiological ProductsBiofilmEscherichia coliNatural compoundsNew therapeutic approaches

Identifiers

PMID40844704

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.